- What is FMS's free cash flow?
- Fresenius Medical Care AG & Co. KGaA (FMS)'s trailing-twelve-month free cash flow is $1.77 billion for the twelve months ended March 31, 2026 — operating cash flow minus capital expenditures. FCF is the strongest signal of a company's ability to fund dividends, buybacks, and growth without external financing. The FCF card on this page shows the annual + quarterly trend.
- What is FMS's operating cash flow?
- Fresenius Medical Care AG & Co. KGaA's trailing-twelve-month operating cash flow is $2.72 billion for the twelve months ended March 31, 2026 — cash generated from core business activities, before capital expenditures and financing. The OCF card on this page shows the annual and quarterly trend.
- How much does FMS spend on capital expenditures?
- Fresenius Medical Care AG & Co. KGaA (FMS)'s trailing-twelve-month capital expenditures total $947.1 million for the twelve months ended March 31, 2026. The CapEx card on this page shows the trend over time, revealing how aggressively the company is investing in future growth vs harvesting current operations.
- How current is FMS's cash flow data?
- Fresenius Medical Care AG & Co. KGaA (FMS)'s cash-flow figures on this page cover the twelve months ended March 31, 2026. They refresh as each new 10-Q and 10-K filing is parsed, typically within 48 hours of SEC submission.
